Listing 1 - 2 of 2 |
Sort by
|
Choose an application
This searing indictment, David Healy's most comprehensive and forceful argument against the pharmaceuticalization of medicine, tackles problems in health care that are leading to a growing number of deaths and disabilities. Healy, who was the first to draw attention to the now well-publicized suicide-inducing side effects of many anti-depressants, attributes our current state of affairs to three key factors: product rather than process patents on drugs, the classification of certain drugs as prescription-only, and industry-controlled drug trials. These developments have tied the survival of pharmaceutical companies to the development of blockbuster drugs, so that they must overhype benefits and deny real hazards. Healy further explains why these trends have basically ended the possibility of universal health care in the United States and elsewhere around the world. He concludes with suggestions for reform of our currently corrupted evidence-based medical system.
Pharmacology. --- Medicine. --- Health Workforce --- Drug effects --- Medical pharmacology --- Medical sciences --- Chemicals --- Chemotherapy --- Drugs --- Pharmacy --- Physiological effect --- Drug Industry. --- Drug Utilization. --- addiction. --- american healthcare. --- anti-depressants. --- big pharma. --- blockbuster drugs. --- dangers of prescription drugs. --- drug companies. --- drug use. --- evidence based medical system. --- evidence based medicine. --- healthcare and drugs. --- healthcare and pharamceuticals. --- medical lit. --- medication side effects. --- medications and safety. --- medicine and healthcare. --- mental illness. --- pharmaceutical and biotechnology industry. --- pharmaceutical companies. --- pharmaceuticalization of medicine. --- pharmacy books. --- prescription drug safety. --- universal healthcare.
Choose an application
Why do life-saving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping exposé, Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit. Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line often takes precedence over the advance of medicine. A university biochemist who spent twenty years searching for a single blood protein that later became the best-selling biotech drug in the world, a government employee who discovered the causes for dozens of crippling genetic disorders, and the Department of Energy-funded research that made the Human Genome Project possible--these engrossing accounts illustrate how medical breakthroughs actually take place. The
Pharmaceutical industry. --- Prescription pricing. --- Prescription pricing --- Drugs --- Pharmaceutical industry --- Consumer education --- Public Sector --- Private Sector --- Biomedical Research --- Drug Therapy --- Drug Costs --- Drug Industry --- Research Support as Topic --- Financing, Government --- Health Care Costs --- Therapeutics --- Research --- Industry --- Ownership --- Financing, Organized --- Financial Support --- Social Sciences --- Organization and Administration --- Anthropology, Education, Sociology and Social Phenomena --- Delivery of Health Care --- Costs and Cost Analysis --- Economics --- Technology, Industry, and Agriculture --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Science --- Health Services Administration --- Health Care Quality, Access, and Evaluation --- Health Care Economics and Organizations --- Natural Science Disciplines --- Technology, Industry, Agriculture --- Health Care --- Disciplines and Occupations --- Pharmacy, Therapeutics, & Pharmacology --- Health & Biological Sciences --- Prices --- Consumer education. --- Prices. --- Buyers' guides --- Shoppers' guides --- Drug industry --- Drug trade --- Consumer affairs departments --- Consumers' leagues --- Education --- Home economics --- Shopping --- Medicine industry --- Medicines industry --- Prescription medicine industry --- Chemical industry --- Pricing --- american society. --- biochemists. --- biotech drugs. --- drug companies. --- drug cost. --- drug culture. --- drug funding. --- drug innovation. --- drug manufacturing. --- drug pricing. --- expose piece. --- genetic disorders. --- government funded research. --- high costs. --- human genome project. --- investments. --- medical breakthroughs. --- medical innovations. --- medical research. --- pharmaceutical companies. --- prescription drugs. --- private sector. --- public heath. --- public sector. --- research and development. --- us government.
Listing 1 - 2 of 2 |
Sort by
|